Clinical Trials Browser

Phase 2 × Withdrawn × Cryotherapy × Clear all

NCT03484962 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Liver Cancer

Phase 2 Withdrawn

Gastrointestinal

Liver Neoplasms

NCT03501056 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Lung Cancer

Phase 2 Withdrawn

Lung Neoplasms

NCT03509298 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Pancreatic Cancer

Phase 2 Withdrawn

Gastrointestinal

Pancreatic Neoplasms

NCT03524261 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Breast Cancer

Phase 2 Withdrawn

Breast Neoplasms

NCT03524274 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Colorectal Cancer

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

NCT03540199 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Kidney Cancer

Phase 2 Withdrawn

Kidney Neoplasms

NCT03554395 2020-10-19

Study of Activated Cytokine-induced Killer Armed With Bispecific Antibody for Advanced Gastric Cancer

Phase 2 Withdrawn

Gastrointestinal

Stomach Neoplasms

NCT02961816 2017-04-21

Panobinostat Combined With High-Dose Gemcitabine/Busulfan/Melphalan With Autologous Stem Cell Transplant for Patients With Refractory/Relapsed Lymphoma

Phase 2 Withdrawn

Hodgkin Disease, Lymphoma, Lymphoma, T-Cell, Lymphoma, Large B-Cell, Diffuse